Nuedexta for Pseudobulbar Affect
The Carlat Psychiatry Report, Volume 10, Number 1, January 2012
Steve Balt, MD
Research fellow, Addiction Pharmacology Research Laboratory, California Pacific Medical Center
Dr. Balt discloses that his spouse is employed as a sales representative for Bristol Myers Squibb.
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Nuedexta is a combination of dextromethorphan (DM) and quinidine sulfate. You might reasonably ask why these two agents would have ever been considered as a treatment for PBA.